Published: 05 November, 2017 | Volume 1 - Issue 3 | Pages: 083-086
Figure 1:
A 69-year-old prostate cancer patient treated hormonal and chemotherapy presented with radiotracer avid extensive skeletal and lymph node metastasis on pre-therapy diagnostic 68Ga-PSMA-HBED-CC PET/CT scan [a,e,f,g, (red arrows)] and 1st cycle of 177Lu-PSMA-DKFZ-617 24 hr anterior and posterior whole body scintigraphy (WBS) (b). After the 5th cycle the post-therapy 177Lu-PSMA-DKFZ-617 scan revealed complete resolution of all lesions except with residual disease in D4 vertebra and left scapula (c). Intrim 68Ga-PSMA-HBED-CC PET/CT scan demonstrated decreased PSMA uptake, size and number of lesions (d,h,i) with residual disease in the D4 vertebra, left 5th rib and left scapula [d (black arrow), j(white arrows)] consistent with near complete response.
Read Full Article HTML DOI: 10.29328/journal.jro.1001012 Cite this Article Read Full Article PDF
HSPI: We're glad you're here. Please click "create a new Query" if you are a new visitor to our website and need further information from us.
If you are already a member of our network and need to keep track of any developments regarding a question you have already submitted, click "take me to my Query."